Daiichiro Hasegawa

No abstract is available for this article. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Supporting Information Filename Description cga70042-sup-0001-TableS1.docxWord 2007 document , 18.3 KB Table S1: The results of anemia-related tests.

LETTER TO THE EDITOR Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation Tomoko Fujikawa, Tomoko Fujikawa Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan Search for more papers by this authorSuguru Uemura, Corresponding Author Suguru Uemura Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan Correspondence Suguru Uemura, Department of...

No abstract is available for this article. REFERENCES 1, , , , , Atypical teratoid/rhabdoid tumour. In: the WHO Classification of Tumours Editorial Board, editor. WHO classification of tumours, central nervous system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2021. p. 221– 225. 2, , , , , , et al. Low-dose histone deacetylase inhibitor treatment leads to tumor growth arrest and multi-lineage differentiation of malignant rhabdoid tumors. Clin Cancer Res. 2016; 22: 3560– 3570.